PeptidesInfo
Safety

Counterfeit and Fake GLP-1 Products: How to Spot Them

Fake and counterfeit versions of semaglutide and tirzepatide are being sold online, sometimes with made-up pharmacy labels. Here is how the FDA says to recognize them and buy safely.

Abstract lattice illustration for the counterfeit GLP-1 products guide
Contents
  1. What "counterfeit" means here
  2. What the FDA has actually seen
  3. The warning signs, straight from the FDA
  4. Two more traps to know about
  5. How to buy safely
  6. The bottom line
  7. Where to go next

Key findings

  1. 1The FDA says it is aware of fraudulent compounded semaglutide and tirzepatide sold online with false or nonexistent pharmacy names on the label.
  2. 2There has been a report of a fake compounded tirzepatide causing redness, swelling, pain and a lump at the injection site.
  3. 3Injectable GLP-1 drugs must stay cold; the FDA says do not use any that arrive warm.
  4. 4The FDA lists clear red flags — "same as" claims, prices that are too good, missing licensed-clinician oversight, and sloppy or fake labels.
  5. 5The safe route is a prescription filled at a state-licensed pharmacy; the FDA's BeSafeRx program helps check an online pharmacy.

Evidence level

Established evidence

The warning signs and reports here come directly from the FDA's page on unapproved GLP-1 drugs, verified against that source. Counterfeit and fraudulently labeled products are, by definition, not FDA-approved and of unknown content.

Regulatory status

Not FDA-approved

Only the brand-name GLP-1 products (Ozempic, Wegovy, Rybelsus; Mounjaro, Zepbound) are FDA-approved. Counterfeit copies are illegal and unregulated, and what is actually in them is unknown.

Demand for weight-loss drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has pulled in scammers. The FDA says fake and fraudulently labeled versions are being sold online - some with pharmacy names that do not even exist. Here is how to spot them, in plain terms.

What "counterfeit" means here

A counterfeit drug is a fake made to look real. With GLP-1 drugs, that can mean a vial with an official-looking label naming a pharmacy that is fake or does not exist - selling something whose real contents nobody has checked[1].

This is different from legally compounded medicine, which a licensed pharmacy actually makes. We cover that side in compounded semaglutide: what the FDA actually says. This article is about outright fraud.

What the FDA has actually seen

The FDA says it is aware of fraudulent compounded semaglutide and tirzepatide being sold, with false or nonexistent pharmacy names printed on the label[1].

It also points to real harm. There is a report of a fake compounded tirzepatide that caused redness, swelling, pain and a lump at the injection site. Separately, the FDA has received reports of harm - some serious enough to need a hospital - from dosing errors with compounded injectable semaglutide[1].

These are not hypothetical risks. They are things the FDA says have already happened.

The warning signs, straight from the FDA

The FDA lists clear red flags for these products[1]. Treat any of these as a reason to stop:

  • "Same as" claims. A seller says the product is "the same as" the FDA-approved drug. It is not - an approved product went through FDA review; a copy did not.
  • Prices that are too good to be true. Deep discounts and bargain pricing are a common lure.
  • The medicine looks off. It looks different from what you had before, or shows up in damaged packaging with no instructions.
  • No real clinician. No licensed doctor reviews you before you get the drug, and none is available afterward for questions.
  • Sloppy or fake labels. Spelling mistakes, a wrong address, or a pharmacy name you cannot find or verify.

Two more traps to know about

Warm shipments. Injectable GLP-1 drugs need to stay cold. The FDA has had complaints of products arriving warm or with too little ice, and it advises not using any injectable GLP-1 drug that arrives warm - heat can ruin it[1].

"Research use only" vials. Some sellers label products "for research purposes" or "not for human consumption," then sell them to people to inject anyway, sometimes with dosing instructions. The FDA is clear these are unapproved drugs of unknown quality - the label is a dodge, not a safety feature[1]. We explain how to read a real quality document in our certificate of analysis guide.

How to buy safely

The FDA's advice is short[1]:

  1. Get a prescription from a licensed healthcare provider.
  2. Fill it at a state-licensed pharmacy. A safe pharmacy asks for that prescription - it does not skip the step.
  3. Check an online pharmacy first. The FDA runs a program called BeSafeRx to help people tell safe online pharmacies from risky ones.
  4. Do not use anything that arrives warm, looks wrong, or came without a clinician involved.

The bottom line

The safest GLP-1 product is a prescribed one from a licensed pharmacy. If a deal skips the prescription, skips the clinician, or ships from a "pharmacy" you cannot verify, the FDA's own warnings say to walk away - because with a counterfeit, the one thing you can count on is that nobody trustworthy has checked what is in it.

Where to go next

Frequently asked questions

How do I know if my semaglutide or tirzepatide is fake?
There is no way to be fully sure at home, but the FDA lists warning signs such as a label with spelling errors, a wrong or made-up pharmacy address, packaging that looks different from before, no licensed clinician involved, and prices that seem too good to be true.
Has anyone actually been hurt by a fake GLP-1 product?
Yes. The FDA describes a report of fake compounded tirzepatide that caused redness, swelling, pain and a lump where it was injected. The FDA has also received reports of harm from dosing errors with compounded semaglutide.
What should I do if my injectable GLP-1 drug arrives warm?
The FDA says do not use it. These drugs must be kept cold in shipping, and heat can ruin the drug's quality.
How can I check whether an online pharmacy is legitimate?
The FDA runs a program called BeSafeRx to help people spot safe online pharmacies. A safe pharmacy requires a valid prescription and is licensed in your state.

References

Numbered in order of first use. Study type is shown for every source; see our methodology for how we rank evidence.

  1. 1.

    FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss U.S. Food and Drug Administration, 2026.

    Regulatory source

    Result: FDA is aware of fraudulent compounded semaglutide/tirzepatide with false or nonexistent pharmacy labels; reports include an injection-site reaction from fake tirzepatide; lists consumer red flags and directs buyers to state-licensed pharmacies and BeSafeRx.

    ↑ back to text

Review status: Editorially reviewed against primary sources. This article was fact-checked against the primary sources listed in the references by our editorial team, and it has not been reviewed by a licensed clinician. It is educational content, not medical advice. Read our editorial policy and methodology. Spotted an error? Tell us.

counterfeit peptidesfake semaglutideGLP-1tirzepatidebuying safely

Continue researching

Related analyses, profiles, and research areas

Recommendations are ranked by shared peptides, research areas, evidence level, and topic tags — not by popularity.

Peptide profiles

Research analysis5 min read

GLP-1 Peptides: Established Uses Versus Emerging Research

Semaglutide and tirzepatide are the best-evidenced peptides in medicine — for specific uses. We separate the approved indications with large trials from the emerging research (kidney, liver, heart failure, sleep apnoea, Alzheimer's) and the open questions about regain, muscle loss and compounded products.

Safety5 min read

Peptide Purity, Contamination, and the Limits of a Certificate of Analysis

A certificate of analysis is the main reassurance offered by 'research peptide' vendors. Here is what a CoA can and cannot tell you — identity, purity, quantity, sterility, endotoxin — why '99% pure' is not what it sounds like, and what independent testing of grey-market peptides has found.

Regulation4 min read

Compounded Semaglutide: What the FDA Actually Says

Compounded semaglutide is not the same as Ozempic or Wegovy. It is not FDA-checked, the shortage that made it common is over, and the FDA has linked it to dosing errors and hospital visits. Here is the plain version.